These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2993833)

  • 1. Neutralising antibody against type 1 and type 2 herpes simplex virus in cervical mucus of women with cervical intra-epithelial neoplasia.
    Murphy JF; Murphy DF; Barker S; Mylotte ML; Coughlan BM; Skinner GR
    Med Microbiol Immunol; 1985; 174(2):73-80. PubMed ID: 2993833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody activity to type 1 and type 2 herpes simplex virus in human cervical mucus.
    Coughlan BM; Skinner GR
    Br J Obstet Gynaecol; 1977 Aug; 84(8):622-9. PubMed ID: 196613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of type-specific antibody against type 1 and type 2 herpes simplex virus in women with abnormal cervical cytology: evidence towards pre-pubertal vaccination of sero-negative female subjects.
    Skinner GR; Whitney JE; Hartley C
    Arch Virol; 1977; 54(3):211-21. PubMed ID: 196578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlamydia trachomatis and herpes simplex virus IgA antibodies in cervical secretions of patients with cervical atypia.
    Kalimo K; Terho P; Honkonen E; Grönroos M; Halonen P
    Br J Obstet Gynaecol; 1981 Nov; 88(11):1130-4. PubMed ID: 6271164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study on the relationship between cervical neoplasia and herpes simplex type-2 virus. II. Herpes simplex type-2 antibody presence in sera taken at enrollment.
    Vonka V; Kanka J; Hirsch I; Závadová H; Krcmár M; Suchánková A; Rezácová D; Broucek J; Press M; Domorázková E
    Int J Cancer; 1984 Jan; 33(1):61-6. PubMed ID: 6319297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of herpes simplex type 2 virus with cervical cancer of the uterus.
    Kao CL; Chen YH; Tang MC; Wen HK; Hsia S
    Taiwan Yi Xue Hui Za Zhi; 1974 Feb; 73(2):122-7. PubMed ID: 4368434
    [No Abstract]   [Full Text] [Related]  

  • 7. Neutralizing antibodies to herpesvirus types 1 and 2 in carcinoma of the cervix, carcinoma in situ and cervical dysplasia.
    McDonald AD; Williams MC; Manfreda J; West R
    Am J Epidemiol; 1974 Aug; 100(2):130-5. PubMed ID: 4368955
    [No Abstract]   [Full Text] [Related]  

  • 8. Chlamydia trachomatis and cervical neoplasia.
    Schachter J; Hill EC; King EB; Heilbron DC; Ray RM; Margolis AJ; Greenwood SA
    JAMA; 1982 Nov; 248(17):2134-8. PubMed ID: 6288978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex type 2 virus and cervical neoplasia.
    Vonka V; Kanka J; Roth Z
    Adv Cancer Res; 1987; 48():149-91. PubMed ID: 3039809
    [No Abstract]   [Full Text] [Related]  

  • 10. Increasing antibody titers to herpes simplex virus type 2 during follow-up of women with cervical dysplasia.
    Sprecher-Goldberger S; Thiry L; Gould I; Fassin Y; Gompel C
    Am J Epidemiol; 1973 Feb; 97(2):103-10. PubMed ID: 4347508
    [No Abstract]   [Full Text] [Related]  

  • 11. Herpes simplex virus antibody in south Indian patients with carcinoma cervix.
    Seshadri L; Seth P; Walter A; Seshadri MS; John TJ
    Indian J Med Res; 1984 Jan; 79():13-8. PubMed ID: 6327511
    [No Abstract]   [Full Text] [Related]  

  • 12. A study of herpes simplex type 2 antibody status in groups of patients with cervical neoplasia in Czechoslovakia.
    Janda Z; Kanka J; Vonka V; Svoboda B
    Int J Cancer; 1973 Nov; 12(3):626-30. PubMed ID: 4364794
    [No Abstract]   [Full Text] [Related]  

  • 13. Herpes simplex virus type 2 and carcinoma of cervix uteri.
    Vardthananusara C; Wasi C; Usavajindawatn C; Thongchareon P
    J Med Assoc Thai; 1978 Jan; 61(1):14-9. PubMed ID: 204721
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic significance of herpes simplex virus antibody status in women with cervical intraepithelial neoplasia (CIN).
    Coleman DV; Morse AR; Beckwith P; Anderson MC; Gardner SD; Knowles WA; Skinner GR
    Br J Obstet Gynaecol; 1983 May; 90(5):421-7. PubMed ID: 6303385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study on the relationship between cervical neoplasia and herpes simplex type 2 virus. III. Presence of herpes simplex type-2 antibody in sera of subjects who developed cervical neoplasia later in the study.
    Krcmár M; Suchánková A; Kanka J; Vonka V
    Int J Cancer; 1986 Aug; 38(2):161-5. PubMed ID: 3015805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex partners and herpes simplex virus type 2 in the epidemiology of cancer of the cervix.
    Graham S; Rawls W; Swanson M; McCurtis J
    Am J Epidemiol; 1982 May; 115(5):729-35. PubMed ID: 6282116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer: patterns of neutralizing antibodies.
    Christenson B; Espmark A
    Am J Epidemiol; 1977 Apr; 105(4):296-302. PubMed ID: 192072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes simplex type 2 neutralization antibodies in patients with cancers of urinary bladder, prostate, and cervix.
    Lüleci G; Sakizli M; Günalp A; Erkan I; Remzi D
    J Surg Oncol; 1981; 16(4):327-31. PubMed ID: 6265707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of indirect hemagglutination test to measurement of type specific antibody to herpes simplex virus in human sera.
    Ohashi M; Ozaki Y
    Microbiol Immunol; 1979; 23(8):801-4. PubMed ID: 232237
    [No Abstract]   [Full Text] [Related]  

  • 20. Estimation of specific antibody to type 2 Herpes simplex virus among patients with carcinoma of the uterine cervix.
    Kawana T; Yoshino K; Kasamatsu T
    Gan; 1974 Oct; 65(5):439-45. PubMed ID: 4373302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.